好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Longitudinal Progression of Subcortical Structural Damage in Amyotrophic Lateral Sclerosis
Neuromuscular and Clinical Neurophysiology (EMG)
P5 - Poster Session 5 (5:30 PM-6:30 PM)
11-002
Our specific aim was to explore the longitudinal evolution of structural damage to subcortical and hippocampal structures in a cohort of incident amyotrophic lateral sclerosis (ALS) patients.
Converging evidence suggests an early involvement of subcortical structures in the course of neuropathological progression underlying the development of ALS. However, the longitudinal evolution of such damage along the clinical progression of the disease still needs to be clarified.

In the present study, we included 24 patients with a clinical diagnosis of ALS and 34 age- and sex-matched healthy controls who underwent at least two longitudinal clinical evaluations and brain MRI scans on a 3 Tesla scanner (median follow-up time = 0.96 years). Age- and sex-adjusted ANOVA models were performed between groups at baseline. Linear mixed effect models were used to test differences of longitudinal trajectories between patients and controls. Results were Bonferroni-corrected for multiple comparisons.

At baseline, ALS patients showed significant bilateral reduction of hippocampal volumes compared with healthy controls (left: p=0.05; right: p=0.038), and a trend toward significance for atrophy in the right thalami (p=0.08). Baseline volumes of the basal ganglia were comparable between patients and controls. Longitudinally, ALS patients showed a significant reduction of grey matter volumes of the left pallidum (p=0.01) and right putamen (p=0.02).

The results of this longitudinal analysis suggest a different temporal involvement of hippocampal and subcortical structures in the course of ALS, with an early involvement of hippocampi and thalami followed by a subsequent progression of damage to the basal ganglia. Our study highlights the importance of evaluating subcortical structural alterations for a more comprehensive pathophysiological understanding of ALS and supports the use of MRI volumetric measures for tracking disease progression.

Authors/Disclosures
Edoardo G. Spinelli, MD
PRESENTER
Dr. Spinelli has nothing to disclose.
Alma Ghirelli No disclosure on file
Silvia Basaia Silvia Basaia has nothing to disclose.
Elisa Canu (Ospedale San Raffaele) The institution of Elisa Canu has received research support from Italian Ministry of Health .
Veronica Castelnovo, MSc (San Raffaele Scientific Institute, Vita-Salute San Raffaele University) Dr. Castelnovo has nothing to disclose.
Tommaso Russo, MD (MassGeneral Institute for Neurodegenerative Diseases) Dr. Russo has nothing to disclose.
Paride Schito Paride Schito has nothing to disclose.
Yuri Falzone Yuri Falzone has nothing to disclose.
Massimo Filippi, MD, FAAN (Ospedale San Raffaele, Neuroimaging Research Unit) Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Federica Agosta (San Raffaele Scientific Institute) Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.